Banco BBVA Argentina reports today against a backdrop that is more complicated than its ORTEX stock score suggests. The bank carries a near-peak composite score of 88.2, driven by exceptional forward earnings momentum, yet the stock has shed 23% in the past month and is trailing its closest local peers into the print.
The relative underperformance is the central tension. Over the past week, BBAR recovered 4.8% — a reasonable bounce — but domestic rivals ran harder. Banco Supervielle gained 17% on the week. BHIP added 18%. Even Grupo Financiero Galicia and Banco Macro posted gains of 7.6% and 6% respectively. BBAR's one-month loss of 23% stands out as the sharpest pullback in the peer group, and the gap has not closed. That divergence is what today's numbers need to address.
The growth case is legitimately striking. The 12-month forward EPS growth estimate sits in the 98th percentile of the ORTEX universe, a reading that reflects the sharp earnings recovery playing out across Argentine banking as inflation stabilises and loan demand returns. The 90-day EPS momentum score ranks in the 97th percentile, confirming that analyst revisions have been consistently and strongly positive. Dividend score ranks in the 87th percentile. The valuation, at a price-to-book of roughly 0.34 and a PE around 2.4x, looks undemanding on paper — though for an Argentine bank reporting in ARS, those multiples carry the structural noise that always comes with local-currency inflation accounting.
The institutional flow adds nuance. Parent Banco Bilbao Vizcaya Argentaria holds 66% of shares and has not moved. The Argentine Social Security Administration holds a further 8%. Below those anchors, several active funds built positions through Q2: Samlyn Capital added roughly 1.8 million shares, Aquamarine Financial added 1.4 million, and Itau USA Asset Management added 1.4 million — all reported as of 30 June. The one notable trim came from Morgan Stanley, which cut its holding by 918,000 shares over the same period. The net direction among active managers was accumulation, which gives the bull case some institutional backing even as the stock lagged.
The quality pillar is the bearish counterpoint. ORTEX quality scores modestly at 61.3, held back by a near-zero return on capital employed and a weak F-score of 2 — a pattern shared across the Argentine banking sector but one that keeps value-oriented investors cautious. After the May earnings print, the stock gained 6% on the day and 10% over the following five days. Today's report is therefore less a test of whether BBAR can grow earnings and more a test of whether the pace of that recovery justifies buying it at a 23% discount to where it traded a month ago, while faster-moving peers have already rerated higher.
See the live data behind this article on ORTEX.
Open BBAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
